Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
COmuNiCaziONi ORali<br />
references<br />
1 Robbins SL. Pathology, 3rd ed. Philadelphia: W. Saunders, Co. 1967,<br />
p. 614.<br />
2 Fletcher CDM, Unni KK, Mertens F (Eds). World Health Organisation<br />
Classification of Tumours. Pathology and genetics of tumours of<br />
soft tissue and bone. IARC Press: Lyon 2002.<br />
3 Fletcher C. The evolving concept of hemangioendothelioma. British<br />
Division of IAP 2006.<br />
4 Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution<br />
of an oncofetal antigen (M2Aantigen) expressed on testicular<br />
germ cell tumours. Br J Cancer 1999;80:569-78.<br />
5 Bailey D, Baumal R, Law J, et al. Production of a monoclonal antibody<br />
specific for seminomas and dysgerminomas. Proc Natl Acad Sci<br />
USA 1986;83:5291-5.<br />
6 Bailey D, Marks A, Stratis M, et al. Immunohistochemical staining of<br />
germ cell tumors and intratubular malignant germ cells of the testis<br />
using antibody to placental alkaline phosphatase and a monoclonal<br />
antiseminoma antibody. Mod Pathol 1991;4:167-71.<br />
7 Sonne SB, Herlihy AS, Hoei-Hansen CE, et al. Identity of M2A<br />
(D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human<br />
developing testis, testicular carcinoma in situ and germ-cell tumours.<br />
VirchowsArch 2006;449:200-6.<br />
8 Stein JJ. Hemangioendothelioma of the testis. J Urol 1975;113:201-3.<br />
9 Cricco CF Jr, Buck AS. Hemangioendothelioma of the testis: second<br />
reported case. J Urol 1980;123:131-2.<br />
10 Hilary K, Hargreaves HK, Scully RE, et al. Benign hemangioendothelioma<br />
of the testis: case report with electron microscopic<br />
documentation and review of the literature. Am J Clin Pathol<br />
1982;77:637-42.<br />
CIntec® PLUS immunocytochemistry:<br />
a tool for the cytological diagnosis<br />
of glandular lesions of the cervix uteri<br />
A. Ravarino1 , S. Nemolato1 , E. Macciocu2 , M. Fraschini3 ,<br />
G. Senes1 , G. Faa1 , G. Negri2 1 Department of Pathology, University Hospital San Giovanni di Dio of<br />
Cagliari, Italy, 2 Department of Pathology, Central Hospital Bolzano, Bolzano,<br />
Italy; 3 Department of Electrical and Electronic Engineering, Univeristy<br />
of Cagliari, Italy<br />
Cytology of glandular lesions of the cervix uteri is sometimes difficult<br />
to evaluate because reactive conditions of the endocervical<br />
epithelia may mimic neoplasia. CINtec PLUS is a novel biomarker<br />
that combines p16 and Ki67 using a double stain technique.<br />
In squamous lesions of the cervix uteri, CINtec Plus has already<br />
shown a high sensitivity and specificity 1 . As far as we know,<br />
however, no study evaluated CINtec PLUS on a large group of<br />
histology-confirmed glandular lesions of the cervix uteri.<br />
In this study, we evaluated the usefulness of CINtec PLUS p16/<br />
Ki-67 double stain for the diagnosis of glandular lesions of the<br />
cervix uteri in liquid-based cytologic specimens 2 .<br />
The study included 47 abnormal ThinPrep (Hologic) liquid-based<br />
cytologies with a subsequent histological diagnosis of adenocarcinoma,<br />
in situ or with early invasion, and 16 samples with negative<br />
follow-up. All samples were stained with CINtec PLUS p16/<br />
Ki-67 double stain (Roche-mtm, Heidelberg).<br />
Of the neoplastic samples, 7 were excluded because of insuf-<br />
Tab. I. CiNtec pluS immunocytochemistry in 63 liquid-based cytologies.<br />
323<br />
ficient residual cellularity or loss of neoplastic cells. Of the adequate<br />
samples, 92.5% were stained with Cintec PLUS (Fig. 1),<br />
whereas 7.5% were judged inconclusive. The samples of all inconclusive<br />
cases had been stored at room temperature for at least<br />
3 years. Of the 16 negative samples, 15 (93.8%) stained negative<br />
and only one (6.2%) showed positive clusters of cells (Tab. I).<br />
By applying the Fisher’s exact test sensitivity, specificity, positive<br />
predictive value, and negative predictive value were 93.75%,<br />
97.37%, 83.33% and 92.50% respectively.<br />
In conclusion, our study shows that CINtec PLUS may be helpful<br />
for the diagnosis of glandular lesions of the cervix uteri and<br />
may reduce the risk of false negatives as well as the number of<br />
uncertain borderline reports.<br />
references<br />
1 Schmidt D, Bergeron C, Denton KJ, et al. European CINtec Cytology<br />
Study Group. p16/Ki-67 Dual-Stain cytology in the triage of ASCUS<br />
and LSIL papanicolaou cytology: results from the european equivocal<br />
or mildly abnormal papanicolaou cytology study. Cancer Cytopathol<br />
2011;119:158-66.<br />
2 Ravarino A, Nemolato S, Macciocu E, et al. Evaluation of CINtec®<br />
PLUS immunocytochemistry as a tool for the cytological diagnosis of<br />
glandular lesions of the cervix uteri. Am J Clin Pathol <strong>2012</strong>, in press.<br />
Large cell neuroendocrine carcinoma of the ovary<br />
associated with well differentiated neuroendocrine<br />
tumor of the appendix<br />
B.J. Rocca1 , M.R. Ambrosio1 , M.A.G.M. Butorano1 , A. Ginori1 ,<br />
A. Ambrosio2 , C. Cardone1 , M. Vestri1 , R. Santopietro1 1 Department of Human Pathology and Oncology, Pathological Anatomy<br />
Section, University of Siena, Italy; 2 University “Magna Graecia” of Catanzaro,<br />
Italy<br />
Background. neuroendocrine differentiation may be documented<br />
in a variety of ovarian tumors including surface epithelial tumors,<br />
Follow-up CINtec + CINtec - Inconclusive Inadeguate Total<br />
Positive 37 (92.5%) 0 3 (7.5%) 40<br />
Negative 1 (6.2%) 15 (93.8%) 0 16<br />
Excluded 2* 5 7<br />
total 38 17 3 5 63<br />
* no residual neoplastic cells<br />
Fig. 1. aiS. Sheet of positive cells: the red-stained nuclei are readily<br />
evident on the background of the brown-stained cytoplasm (40x).